Abstract
Background/Aim: It is well known that Helicobacter pylori changes its shapes according to various environmental conditions. The aim of this study was to examine the morphological differences between H. pylori in the duodenum and that in the stomach. Methods: Duodenal biopsy specimens were obtained from patients with duodenal mucosal lesions, and these specimens were then histopathologically examined. Morphological and genetic properties of cultured H. pylori isolates were analyzed. Results:H. pylori was identified in 16 out of 50 duodenal biopsy specimens. Along with the regular form, we found a fine form of H. pylori in the gastric metaplastic mucosa of ten duodenal specimens that was shorter in length and thinner in diameter than the regular helical form. There were no detectable differences between the ureA-ureB polymorphism of the duodenal fine form and that of gastric regular form in a single patient. As compared with patients without H. pylori in the duodenum, the prevalence of recurrent duodenal ulcers significantly increased in patients with the fine form (p < 0.05), but not in patients with the regular form. Conclusion: The fine form of H. pylori in the metaplastic duodenal mucosa could result from its adaptation to the duodenal environment and may be associated with the recurrence of a duodenal ulcer.
Journal Section:
Original Paper: <i>Helicobacter pylori</i>
References
1.
Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;i:1311–1315.
2.
Jiang SJ, Lui WZ, Zhang DZ, Shi Y, Xiao SD, Zhang ZH, Lu DY: Campylobacter-like organisms in chronic gastritis, peptic ulcer, and gastric carcinoma. Scand J Gastroenterol 1987;22:553–558.
[PubMed]
3.
Graham DY: Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96:615–625.
[PubMed]
4.
Blaser MJ: Helicobacter pylori and pathogenesis of gastroduodenal inflammation. J Infect Dis 1993;161:626–633.
5.
Khulusi B, Badve S, Patel P, Lloyd R, Marrero JM, Finlayson C, Mendall MA, Northfield TC: Pathogenesis of gastric metaplasia of the human duodenum: Role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology 1996;110:452–458.
[PubMed]
6.
Warren JR, Marshall B: Unidentified curved bacilli on gastric epithelium in chronic gastritis. Lancet 1983;i:1273–1275.
7.
Bode G, Mauch F, Malfertheiner P: The coccoid forms of Helicobacter pylori: Criteria for their viability. Epidemiol Infect 1993;111:483–490.
[PubMed]
8.
Shahamat M, Mai U, Paszuko-Kolva C, Kessel M, Colwell RR: Use of radioautography to assess viability of Helicobacter pylori in water. Appl Environ Microbiol 1993;59:1231–1235.
[PubMed]
9.
Cellini L, Allocati N, Angelucci D: Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol 1994;38:843–850.
[PubMed]
10.
Lessells AM, Martin DF: Heterotopic gastric mucosa in the duodenum. J Clin Pathol 1982;35:591–595.
[PubMed]
11.
Hiraga S, Niki H, Ogura T, Ichinose C, Mori H, Ezaki B, Jaffé A: Chromosome partitioning in Escherichia coli: Novel mutants producing anucleate cells. J Bacteriol 1989;171:1496–1505.
[PubMed]
12.
Foxall PA, Hu L-T, Mobley HLT: Use of polymerase chain reaction-amplified Helicobacter pylori urease structural genes for differentiation of isolates. J Clin Microbiol 1992;30:739–741.
[PubMed]
13.
Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness E, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenny K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997;388:539–547.
[PubMed]
14.
Takeuchi H, Shirai M, Akada JK, Tsuda M, Nakazawa T: Nucleotide sequence and characterization of cdrA, a cell division-related gene of Helicobacter pylori. J Bacteriol 1998;180:5263–5268.
[PubMed]
15.
Fawcett PT, Gibney KM, Vinette KMB: Helicobacter pylori can be induced to assume the morphology of Helicobacter heilmannii. J Clin Microbiol 1999;37:1045–1048.
[PubMed]
16.
Bode G, Malfertheiner P, Ditschuneit H: Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease. Scand J Gastroenterol 1988;23(suppl 142):25–39.
17.
Wyatt JI, Rathbone BJ, Dixon MF, Heatley RV: Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987;40:841–848.
[PubMed]
18.
Wyatt JI: Helicobacter pylori, duodenitis and duodenal ulceration; in Rathbone BJ, Heatley RV (eds): Helicobacter pylori and Gastroduodenal Disease. London, Blackwell, 1992, pp 140–149.
19.
Wyatt JI, Rathbone BJ, Sobala GM, Shallcross T, Heatley RV, Axon ATR, Dixon MF: Gastric epithelium in the duodenum: Its association with Helicobacter pylori and inflammation. J Clin Pathol 1990;43:981–986.
[PubMed]
20.
Han SW, Evans DG, El-Zaatari FAK, Go MF, Graham DY: The interaction of pH, bile, and Helicobacter pylori may explain duodenal ulcer. Am J Gastroenterol 1996;91:1135–1137.
[PubMed]
21.
Hamlet A, Thoreson A-C, Nilsson O, Svennerholm A-M, Olbe L: Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology 1999;116:259–268.
[PubMed]
22.
Tatsuta M, Iishi H, Yamamura H: Yamamoto R, Taniguchi H: Enhancement by tetragastrin of experimental induction of gastric epithelium in the duodenum. Gut 1989;30:311–315.
[PubMed]
23.
Harris AW, Gummet PA, Walker MM, Misiewicz JJ, Baron JM: Relation between gastric output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb. Gut 1996;39:513–520.
[PubMed]
24.
Owen RJ, Bell GD, Desai M, Moreno M, Gant PW, Jones PH, Linton D: Biotype and molecular fingerprints of metronidazole resistant strains of Helicobacter pylori from antral gastric mucosa. J Med Microbiol 1993;38:4–12.
25.
Hirschl AM, Richter M, Makristathis A, Prückl PM, Willinger B, Schütze K, Rotter ML: Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: Detection by macrorestriction DNA analysis. J Infect Dis 1994;170:473–475.
[PubMed]
26.
Jorgensen M, Daskalopoulos G, Warburton V, Mitchell HM, Hazell SL: Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: Identification from sequential and multiple biopsy specimens. J Infect Dis 1996;174:631–635.
[PubMed]
27.
Wang G, Jiang Q, Taylor DE: Genotype characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. J Clin Microbiol 1998;36:2730–2731.
[PubMed]
28.
Owen RJ, Bickley J, Hurtado A, Fraser A, Pounder RE: Comparison of PCR-based restriction length polymorphism analysis of urease genes with rRNA gene profiling for monitoring Helicobacter pylori infections in patients on triple therapy. J Clin Microbiol 1994;32:1203–1210.
[PubMed]
© 2001 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2001
You do not currently have access to this content.
